Purpose This systematic review aimed to determine the rate and identify correlates of
adherence and persistence over five years of treatment with adjuvant endocrine therapy in …

Objective High rates of non‐adherence to oral medications in breast cancer (BC) patients
have been reported. Here we provide an up‐to‐date systematic review of the interventions …

Adjuvant endocrine therapy (AET) is generally proposed to all patients with hormone
receptor-positive breast cancer to reduce the risk of recurrence and death. Adherence to …

Understanding breast cancer survivors' perspectives is critical to personalizing endocrine
therapy (ET) in the adjuvant setting. A nationwide survey among breast cancer survivors was …

Purpose This retrospective cohort study examined patterns of endocrine therapy initiation
over time and by demographic, tumor, and treatment characteristics. Methods We included …

Importance Suboptimal adherence to endocrine therapy (ET) among patients with hormone-
receptor–positive breast cancer significantly affects survival outcomes and is associated with …

Purpose Breast cancer in men (BC-M) is almost exclusively hormone receptor positive. We
conducted a large review of the SEER-Medicare linked database to compare endocrine …

Background Hormonal therapies are the cornerstone of systemic adjuvant treatment of
oestrogen receptor (ER) positive breast cancer. The full benefit of this treatment is obtained …

Objective The use of adjuvant endocrine therapy (AET) after primary treatment of hormone
receptor‐positive breast cancer reduces the risk of recurrence and mortality. However, non …

Purpose: The aim of this study was to compare estimates of adherence to oral endocrine
therapy (OET) based on real-world data (RWD) and on clinical evaluation in people …